Our present agents, such as allopurinol and probenecid, are so effective, and reasonably safe and predictable, that it seems unlikely that they will be fully displaced in the future
GoodRx explains that GLP-1 medications, such as semaglutide, can increase the risk of dehydration, especially when followed by gastrointestinal side effects such as vomiting or diarrhea and appetite suppression
These results underscore the significance of spike-dependent CFTR reduction following authentic virus infection, and highlight the potential of cardiac glycosides as possible treatments to prevent SARS-CoV-2 infection, CFTR loss and the subsequent inflammatory response
Intracellular delivery of functional proteins and native drugs by cell-penetrating poly(disulfide)s
Advances in Escherichia coli production of therapeutic proteins
If you have looked into GLP-1 medication, most of what you find pushes toward a high target dose and fast results